We demonstrated the prebiotic effect of lacto-Nbiose I (Gal1-3GlcNAc) on bifidobacteria in vitro. Lacto-N-biose I, a building unit of the type-I milk oligosaccharides, enhanced the growth of many bifidobacteria, especially Bifidobacterium bifidum, B. breve, and B. longum, which are predominant in the intestines of breast-fed infants. It might be a substantial, natural prebiotic in human colostrums.
Probiotics are defined by WHO as live microorganisms that confer a beneficial effect on the health of the host when administered in adequate amounts. 1) Bifidobacterium, a genus of Gram-positive anaerobic bacteria, is a well-known probiotic, and is also one of the major groups of commensal microorganisms in the intestinal tracts of healthy humans and animals. Non-digestible food ingredients that promote the growth and/or activity of probiotics are termed prebiotics. Several oligosaccharides, such as raffinose, 2, 3) fructo-oligosaccharide, 4, 5) and galacto-oligosaccharide, [6] [7] [8] are known to function as prebiotics for bifidobacteria, and thus are specifically termed bifidus (or bifidogenic) factors.
Bifidobacteria are predominant in the intestinal tracts of breast-fed infants, but not formula-fed ones, suggesting that human milk contains prebiotic components for bifidobacteria. Substantial bifidus factors in human milk are believed to be comprised of oligosaccharides. Although human milk oligosaccharides are in fact good carbon sources for the efficient growth of several bifidobacterial strains, [9] [10] [11] detailed structural identification of the prebiotic components is still lacking because of the complexity and diversity of structures.
We have determined that bifidobacteria possess a gene cluster encoding the unique metabolic pathway for lacto-N-biose I (Gal1-3GlcNAc), in which the disaccharide is transported to the cytoplasm through a specific ABC-type transporter, 12, 13) phosphorolyzed by galacto-N-biose (Gal1-3GalNAc)/lacto-N-biose I phosphorylase (renamed from lacto-N-biose phosphorylase after the discovery of the lacto-N-biose I specific enzyme), [14] [15] [16] and finally metabolized in the glycolytic and aminosugar metabolic pathways. 17) Although lacto-N-biose I is not present in free disaccharide form in human milk, it occurs as a building unit of type I oligosaccharides, containing lacto-N-tetraose (Gal1-3GlcNAc1-3Gal1-4Glc) as the core structure. Type I oligosaccharides are restricted in the milk of humans and apes, whereas type II oligosaccharides possessing the lacto-N-neotetraose core (Gal1-4GlcNAc1-3Gal1-4Glc) are widely distributed in mammals, including humans. 18) Hence we speculated that lacto-N-biose I in type I oligosaccharides is the minimum unit of bifidus factor in human milk oligosaccharides. In addition, we identified the bifidobacterial lacto-Nbiosidase, an extracellular glycosidase required for releasing lacto-N-biose I from lacto-N-tetraose, confirming our hypothesis. 19) We recently succeeded in large-scale, one-pot synthesis of lacto-N-biose I from sucrose and GlcNAc using four recombinant bifidobacterial enzymes: sucrose phosphorylase, UDP-glucose-hexose-1-phosphate uridylyltransferase, UDP-glucose 4-epimerase, and galacto-N-biose/lacto-N-biose I phosphorylase, in the presence of UDP-Glc and phosphate. 20) This process development enabled us to examine the effects of the disaccharide on selective growth of bifidobacteria in vitro.
The bacterial strains, including 18 bifidobacteria, 8 lactic acid bacteria, and 13 other enterobacteria, were obtained from the Japan Collection of Microorganisms (JCM, RIKEN Bioresource Center, Tsukuba, Japan). The bacteria were inoculated in 5-ml of GAM broth (Nissui Pharmaceutical, Tokyo, Japan) and pre-cultured for 16 h at 37 C under anaerobic conditions using Anaeropack (Mitsubishi Gas Chemical, Tokyo, Japan). A suitable amount of pre-cultured cells were inoculated in 3-ml of GAM broth in the presence and the absence of 0.5% lacto-N-biose I that had been separately sterilized by filtration, and the OD 600 was adjusted to 0.010. After 24 h of cultivation under the same conditions as pre-culture, an aliquot of culture was sampled and 2-fold dilution series were prepared. Cell growth was estimated by measuring OD 600 with a DU800 spectrophotometer (Beckman Coulter, Fullerton, CA). The same tests were independently performed in triplicate (Table 1) .
Lacto-N-biose I exhibited a significant promoting effect on the growth of approximately half of the bifidobacterial strains: viz., Bifidobacterium bifidum JCM1254 and JCM7004; B. longum subsp. infantis JCM1210 and JCM1222
T ; B. longum subsp. longum JCM1217
T and JCM7054; B. breve JCM1192 T ; and B. scardovii JCM12489
T . Among these, the three strains of B. longum exhibited more than twice the growth of y To whom correspondence should be addressed. Tel: +81-75-753-4298; Fax: +81-75-753-9228; E-mail: kiyohara@lif.kyoto-u.ac.jp the controls. However, the growth of the remaining bifidobacteria was hardly promoted. In contrast to most of the bifidobacteria, the lactic acid bacteria, including Lactobacillus and Lactococcus, another group of probiotics, exhibited very weak or no significant change with addition of lacto-N-biose I. Also, the remaining genera, Bacteroides, Clostridium, Enterococcus, Eubacterium, Propionibacterium, and Ruminococcus, were not significantly affected. We subsequently tested the dosedependency of lacto-N-biose I on bifidobacterial growth at concentrations of 0-2.0% (Fig. 1) . The growth of all the strains tested almost linearly increased with increasing concentrations of lacto-N-biose I, and was far superior to the controls at 2.0% concentration. Especially, B. longum subsp. longum JCM1217 T , B. longum subsp. infantis JCM1210, and B. bifidum JCM1254 and JCM7004 grew remarkably (2-3 times greater than the controls). a Prebiotic effect (-fold) = OD 600 value in the presence of 0.5% lacto-N-biose I/OD 600 value in the absence of lacto-N-biose I (n ¼ 3).
Next, we tested the growth of 18 bifidobacterial strains on semisynthetic media containing lacto-N-biose I as sole carbon source in order to determine the ability of these strains to ferment lacto-N-biose I in detail. All bifidobacterial strains were pre-cultured in GAM broth, as described above, and then inoculated to adjust OD 600 = 0.010 in 3-ml of basal medium consisting of 0.5% yeast extract, 1.0% peptone, 0.5% sodium acetate, 0.2% diammonium citrate, 0.02% magnesium sulfate, 0.2% dipotassium hydrogen phosphate, 0.1% Tween 80, 0.08% L-cysteine hydrochloride, 1.36% L-ascorbic acid, and 0.44% sodium carbonate, in the presence and the absence of 0.5% lacto-N-biose I. As positive control, glucose was used in place of lacto-N-biose I. Cultivation was conducted under the conditions described above. Cell growth was monitored by measuring OD 600 at 6, 12, 24, 36, and 48 h. The same tests were independently performed in triplicate. Almost all bifidobacterial strains grew on glucose-supplemented basal media, but we did not observe the growth of B. angulatum JCM7096 T and B. bifidum JCM1255
T on the media (data not shown). Additionally, B. scardovii JCM12489
T grew on basal medium even with no sugar supplementation (data not shown). Hence we excluded these three strains from the evaluation of the fermentability of lacto-N-biose I. The growth curves of nine strains that grew on lacto-Nbiose I-supplemented basal media are shown (Fig. 2) . In good agreement with the results described in Table 1 , B. bifidum JCM1254, JCM7004, B. breve JCM1192 T , B. longum subsp. infantis JCM1210, JCM1222
T , and B. longum subsp. longum JCM1217 T , JCM7054 grew by utilizing lacto-N-biose I as a carbon source ( Fig. 2A-G) . In addition, B. pseudocatenulatum JCM1200 T and B. pseudolongum JCM1205
T , which are not predominant species in infants' intestines, also showed the fermentability of lacto-N-biose I (Fig. 2H and I) . Maximum growth of B. bifidum JCM1254, JCM7004, B. breve JCM1192 T , B. longum subsp. longum JCM7054, and B. pseudocatenulatum JCM1200
T on lacto-N-biose Isupplemented media was larger than that of glucosesupplemented media, suggesting that lacto-N-biose I was preferred as a carbon source over glucose for these strains. On the other hand, the remaining bifidobacterial strains, B. adolescentis JCM1275
T , JCM7046, B. animalis JCM10602
T , B. catenulatum JCM1194 T , B. dentium JCM1195 T , and B. gallicum JCM8224 T , grew on glucose-supplemented basal media but not on lacto-N-biose I-supplemented media (data not shown), indicating that these strains have no ability to ferment lacto-N-biose I.
Eventually, the significantly enhanced species in the GAM broth-based experiments were B. bifidum, B. breve, and B. longum, which are known to be predominant in the intestinal tracts of breast-fed infants. These strains were confirmed to be able to assimilate lacto-N-biose I as a carbon source. On the other hand, the growth of B. adolescentis and B. catenulatum, which are primarily observed in the intestinal tracts of adults, was limited because these strains did not ferment lacto-N-biose I. It is worth noting that the growth of the lactic acid bacteria and other enterobacteria was not enhanced by the addition of this disaccharide. Since 1,3-linked Gal is highly resistant to typical enterobacterialgalactosidases, most enterobacteria are not able to assimilate lacto-N-biose I, except for bifidobacteria, which exhibit an ability to incorporate this disaccharide directly into the cells.
Human milk includes lactose and oligosaccharides, and the latter are composed of more than 130 types of structure. Among the oligosaccharides, lacto-N-tetraose, lacto-N-fucopentaose I (Fuc1-2Gal1-3GlcNAc1-3Gal1-4Glc), lacto-N-difucohexaose I [Fuc1-2Gal1-3(Fuc1-4)GlcNAc1-3Gal1-4Glc], and 2 0 -fucosyllactose (Fuc1-2Gal1-4Glc) are abundant. 21, 22) The former three contain lacto-N-biose I as a building unit of the lacto-N-tetraose core. We have identified bifidobacterial 1,2--L-fucosidase [23] [24] [25] and 1,3-1,4--L-fucosidase (Kiyohara, Miyake, Wada, Katayama, Ashida, and Yamamoto, unpublished results) de-fucosylating the fucose-attached lacto-N-tetraose, and also lacto-N-biosidase cleaving lacto-N-tetraose into lacto-Nbiose I and lactose. 19) These extracellular glycosidases are probably widely distributed in various strains of B. bifidum and B. longum.
We conclude that lacto-N-biose I is a highly specific, natural prebiotic for bifidobacteria, which newborn infants receive for the first time from the colostrums of their mothers. We also expect that lacto-N-biose I supplementation will improve the quality of conventional synthetic milk. The carbon sources used were as follows: lacto-N-biose I (circle); glucose (diamond); none (cross). Species names and strain numbers are indicated in the panels.
